296 related articles for article (PubMed ID: 30113799)
1. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
Noda M; Sonoda Y; Takemoto M; Kira R
No To Hattatsu; 2017 May; 49(3):207-10. PubMed ID: 30113799
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide for the treatment of idiopathic intracranial hypertension.
Supuran CT
Expert Rev Neurother; 2015; 15(8):851-6. PubMed ID: 26154918
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.
Samara A; Ghazaleh D; Berry B; Ghannam M
J Med Case Rep; 2019 Apr; 13(1):94. PubMed ID: 30999940
[TBL] [Abstract][Full Text] [Related]
4. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Goyal A; Zarroli K
Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging of Idiopathic Intracranial Hypertension: Before and After Treatment.
Batur Caglayan HZ; Ucar M; Hasanreisoglu M; Nazliel B; Tokgoz N
J Neuroophthalmol; 2019 Sep; 39(3):324-329. PubMed ID: 31430269
[TBL] [Abstract][Full Text] [Related]
6. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
Celebisoy N; Gökçay F; Sirin H; Akyürekli O
Acta Neurol Scand; 2007 Nov; 116(5):322-7. PubMed ID: 17922725
[TBL] [Abstract][Full Text] [Related]
7. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic intracranial hypertension in a young child without visual symptoms or signs.
Winner P; Bello L
Headache; 1996 Oct; 36(9):574-6. PubMed ID: 8916568
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic intracranial hypertension without headache detected during a routine health check].
Sakushima K; Tsuji S; Niino M; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2008 Jun; 48(6):430-2. PubMed ID: 18616157
[TBL] [Abstract][Full Text] [Related]
10. Dural Venous Sinus Stent Placement Reduces Dosage Requirements for Carbonic Anhydrase Inhibitors in Patients with Idiopathic Intracranial Hypertension.
Martin J; Sanborn MR
J Vasc Interv Radiol; 2023 Aug; 34(8):1359-1363. PubMed ID: 37030423
[TBL] [Abstract][Full Text] [Related]
11. [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].
Willenborg KD; Nacimiento W
Ophthalmologe; 2015 Oct; 112(10):814-20. PubMed ID: 26377103
[TBL] [Abstract][Full Text] [Related]
12. The role of opening CSF pressure in response to treatment for idiopathic intracranial hypertension (IIH).
Togha M; Martami F; Rahmanzadeh R; Ghorbani Z; Refaeian F; Behbahani S; Panahi P; Moghadam NB; Nafissi S; Shahbazi M
J Clin Neurosci; 2020 Jun; 76():171-176. PubMed ID: 32331944
[TBL] [Abstract][Full Text] [Related]
13. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
Wilkes BN; Siatkowski RM
J Neuroophthalmol; 2009 Dec; 29(4):281-3. PubMed ID: 19952899
[TBL] [Abstract][Full Text] [Related]
14. External lumbar drainage in progressive pediatric idiopathic intracranial hypertension.
Dotan G; Hadar Cohen N; Qureshi HM; Shapira Rootman M; Nevo Y; Kershenovich A
J Neurosurg Pediatr; 2021 Jul; 28(4):490-496. PubMed ID: 34271543
[TBL] [Abstract][Full Text] [Related]
15. Update on Idiopathic Intracranial Hypertension.
Wall M
Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Intracranial Hypertension in a pubertal paediatric Indian patient.
Aggarwal A; Kaur P; Chhabra K; Singh K; Goyal P
Nepal J Ophthalmol; 2017 Jan; 9(18):74-78. PubMed ID: 29022960
[TBL] [Abstract][Full Text] [Related]
17. Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical/interventional treatments.
House PM; Stodieck SR
Clin Neurol Neurosurg; 2016 Nov; 150():181-184. PubMed ID: 27690252
[TBL] [Abstract][Full Text] [Related]
18. Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients.
Au JN; Waslo CS; McGwin G; Huisingh C; Tanne E
J Neuroophthalmol; 2016 Jun; 36(2):126-30. PubMed ID: 26606175
[TBL] [Abstract][Full Text] [Related]
19. Dural Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A National Database Study of 541 Patients.
Nia AM; Srinivasan VM; Lall R; Kan P
World Neurosurg; 2022 Nov; 167():e451-e455. PubMed ID: 35973522
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
Aguilar-Pérez M; Henkes H
Ophthalmologe; 2015 Oct; 112(10):821-7. PubMed ID: 26400795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
